Glen R. Anderson serves as Executive at Indaptus Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Glen R. Anderson has executed 3 insider transactions totaling $216.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 14, 2023 involved purchasing 23,934 shares valued at $56.0K.
Glen R. Anderson currently holds 1,190,400 shares of Indaptus Therapeutics, Inc. (INDP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Glen R. Anderson has been a net buyer of INDP stock. They have purchased $216.4K and sold $0 worth of shares.
Glen R. Anderson's most recent insider trade was on Aug 14, 2023, when they purchased 23,934 shares at $2.34 per share.
Get notified when new Form 4 filings are submitted
| $2.12 |
| Discretionary |
| Aug 10, 2023 | INDP | $86.0K | Purchase | 44,354 | $1.94 | Discretionary |